Literature DB >> 22401887

Oxidative stress in patients with primary insomnia.

Mustafa Gulec1, Halil Ozkol, Yavuz Selvi, Yasin Tuluce, Adem Aydin, Lutfullah Besiroglu, Pınar Guzel Ozdemir.   

Abstract

OBJECTIVE: Many physiological and pathological processes, such as infections, environmental toxins, and ionizing radiation increase bodily concentrations of oxidizing substances, known as free radicals, which lead to neurodegenerative disorders. Sleep is one of the most important factors contributing to health; however, insomnia is among the most prevalent health complaints.
METHODS: In this study, for the first time in the literature, we investigated the effects of primary insomnia on certain oxidative stress biomarkers. For this purpose, glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), and myeloperoxidase (MPO) activities and levels of reduced glutathione (GSH) and malondialdehyde (MDA) were measured in 30 patients with primary insomnia and 30 healthy volunteers
RESULTS: Our results show that the patients with primary insomnia had significantly lower GSH-Px activity and higher MDA levels compared with the controls.
CONCLUSION: These results may indicate the important role of sleep in attenuating oxidative stress.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22401887     DOI: 10.1016/j.pnpbp.2012.02.011

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  24 in total

Review 1.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

2.  Low-Dose Ozone Therapy Improves Sleep Quality in Patients with Insomnia and Coronary Heart Disease by Elevating Serum BDNF and GABA.

Authors:  Y Li; X Feng; H Ren; H Huang; Yu Wang; S Yu
Journal:  Bull Exp Biol Med       Date:  2021-03-13       Impact factor: 0.804

3.  A nested case-controlled comparison of telomere length and psychological functioning in breast cancer survivors with and without insomnia symptoms.

Authors:  Sheila N Garland; Christina Palmer; Michelle Donelson; Philip Gehrman; F Brad Johnson; Jun J Mao
Journal:  Rejuvenation Res       Date:  2014-10       Impact factor: 4.663

4.  Cell injury and repair resulting from sleep loss and sleep recovery in laboratory rats.

Authors:  Carol A Everson; Christopher J Henchen; Aniko Szabo; Neil Hogg
Journal:  Sleep       Date:  2014-12-01       Impact factor: 5.849

5.  REM-Sleep Deprivation Induces Mitochondrial Biogenesis in the Rat Hippocampus.

Authors:  Soon Ae Kim; Sanga Kim; Hae Jeong Park
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

Review 6.  ROS and brain diseases: the good, the bad, and the ugly.

Authors:  Aurel Popa-Wagner; Smaranda Mitran; Senthilkumar Sivanesan; Edwin Chang; Ana-Maria Buga
Journal:  Oxid Med Cell Longev       Date:  2013-12-05       Impact factor: 6.543

7.  Changes in telomere length and serum neurofilament light chain levels in female patients with chronic insomnia disorder.

Authors:  Chong-Yang Ren; Pei-Pei Liu; Jing Li; Ya-Qiang Li; Li-Jun Zhang; Gui-Hai Chen; Fang-Yi Dong; Dong Hu; Mei Zhang
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

8.  Association between Sleep Quality and Painless Diabetic Peripheral Neuropathy Assessed by Current Perception Threshold in Type 2 Diabetes Mellitus.

Authors:  Dughyun Choi; Bo-Yeon Kim; Chan-Hee Jung; Chul-Hee Kim; Ji-Oh Mok
Journal:  Diabetes Metab J       Date:  2020-08-06       Impact factor: 5.376

Review 9.  Oxidative Dysregulation in Early Life Stress and Posttraumatic Stress Disorder: A Comprehensive Review.

Authors:  Evangelos Karanikas; Nikolaos P Daskalakis; Agorastos Agorastos
Journal:  Brain Sci       Date:  2021-05-29

Review 10.  Oxidative Stress, Inflammation, and Neuroprogression in Chronic PTSD.

Authors:  Mark W Miller; Alex P Lin; Erika J Wolf; Danielle R Miller
Journal:  Harv Rev Psychiatry       Date:  2018 Mar/Apr       Impact factor: 3.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.